CNBC January 31, 2023
Spencer Kimball

Key Points

– The FDA said the end of the public health emergency will not impact its ability to authorize Covid vaccines, tests and treatments on an emergency basis.

– The Biden administration is planning to terminate in May the public health and national emergencies declared in response to the Covid pandemic.

– The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines.

The Food and Drug Administration on Tuesday said its emergency authorizations of Covid vaccines, tests and treatments will not be impacted by the end of the public health emergency this spring.

President Joe Biden is planning to terminate in May the public health and national emergencies declared in response...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Pharma / Biotech, Public Health / COVID
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know

Share This Article